Harbour BioMed reported the appointment of Dr. Xiaoxiang Chen as Executive Vice President, Head of Clinical Development and Regulatory Science. The company announced that Dr. Chen brings to the company more than 20 years of leadership experience in regional and global clinical development, most recently as Boehringer Ingelheim's Vice President, Regional Medical Management for Emerging Markets. In his role as Medical Lead for Emerging Markets at Boehringer Ingelheim, Dr. Chen had overall medical responsibilities, including clinical development, in more than 80 countries and regions, including China, Taiwan, Hong Kong, South Eastern Asia, India, the Middle East and Africa. Previously, he served as Boehringer Ingelheim's Vice President, Head of Medicine Development of China.